Cutting Edge: Serpine1 Negatively Regulates Th1 Cell Responses in Experimental Autoimmune Encephalomyelitis
The Journal of Immunology · 15.12.2023 · 211 (12) · 1762-1766
DOI: 10.4049/jimmunol.2300526 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 01.11.2023. Verfasst von Irshad Akbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, Québec, Canada. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Gouvernement du Canada | Canadian Institutes of Health Research (IRSC), FRQ | Fonds de Recherche du Québec - Santé (FRQS), Multiple Sclerosis Society of Canada (MSSOC).
Abstract (Originalsprache)
Th1 cells are critical in experimental autoimmune encephalomyelitis (EAE). Serine protease inhibitor clade E1 (Serpine1) has been posited as an inhibitor of IFN-γ from T cells, although its role in autoimmunity remains unclear. In this study, we show that Serpine1 knockout (KO) mice develop EAE of enhanced severity relative to wild-type (WT) controls. Serpine1 overexpression represses Th1 cell cytokine production and pathogenicity, whereas Serpine1-KO:2D2 Th1 cells transfer EAE of increased severity in comparison with WT 2D2 Th1 cells. Notably, polarized Serpine1-KO Th1 cells display delayed expression of the Th1-specific inhibitory receptor, Tim-3 (T cell Ig and mucin–domain containing-3). Serpine1-KO:Tim-3-Tg Th1 cells, which transgenically overexpress Tim-3, showed increased expression of IFN-γ and reduced expression of the checkpoint molecules Lag-3 and PD-1 relative to WT Tim-3-Tg counterparts. Furthermore, Serpine1 deficiency restored the EAE phenotype of Tim-3-Tg mice that normally develop mild disease. Taken together, we identify Serpine1 as a negative regulator of Th1 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, Québec, Canada.
- Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA.
- Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA.
- Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA.
- Department of Molecular Medicine, Laval University, Québec, Québec, Canada.
ORCID-Profile: Irshad Akbar, Chen Zhu
Förderung
- Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
- FRQ | Fonds de Recherche du Québec - Santé (FRQS)
- Multiple Sclerosis Society of Canada (MSSOC)
Zitieren
APA
Akbar, I., Tang, R., Baillargeon, J., Roy, A. P., Doss, P. M. I. A., Zhu, C., Kuchroo, V. K., & Rangachari, M. (2023). Cutting Edge: Serpine1 Negatively Regulates Th1 Cell Responses in Experimental Autoimmune Encephalomyelitis. The Journal of Immunology, 211(12), 1762-1766. https://doi.org/10.4049/jimmunol.2300526
Vancouver
Akbar I, Tang R, Baillargeon J, Roy AP, Doss PMIA, Zhu C, et al. Cutting Edge: Serpine1 Negatively Regulates Th1 Cell Responses in Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 2023;211(12):1762-1766. doi:10.4049/jimmunol.2300526
BibTeX
@article{Akbar2023,
author = {Akbar, Irshad and Tang, Ruihan and Baillargeon, Joanie and Roy, Andrée-Pascale and Doss, Prenitha Mercy Ignatius Arokia and Zhu, Chen and Kuchroo, Vijay K and Rangachari, Manu},
title = {Cutting Edge: Serpine1 Negatively Regulates Th1 Cell Responses in Experimental Autoimmune Encephalomyelitis},
journal = {The Journal of Immunology},
year = {2023},
volume = {211},
number = {12},
pages = {1762--1766},
doi = {10.4049/jimmunol.2300526}
}
EUVIMED